NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Published:2004-08-16 Issue:4 Volume:114 Page:569-581
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Huber Margit A.,Azoitei Ninel,Baumann Bernd,Grünert Stefan,Sommer Andreas,Pehamberger Hubert,Kraut Norbert,Beug Hartmut,Wirth Thomas

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference61 articles.

1. NF-κB as a therapeutic target in cancer

2. NF-κB in cancer: from innocent bystander to major culprit

3. NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses

4. Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity

5. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

Cited by 884 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives;Biomedicine & Pharmacotherapy;2024-10

2. How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps;Biomedicine & Pharmacotherapy;2024-09

3. IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial–mesenchymal transition;Cell Communication and Signaling;2024-08-08

4. An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasis;2024-08-03

5. Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development;Frontiers in Pharmacology;2024-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3